Cardlytics (CDLX) Tops Q2 EPS by 20c

Cardlytics (NASDAQ: CDLX) reported Q2 EPS of ($0.65), $0.20 better than the analyst estimate of ($0.85). Revenue for the quarter came in at $75.4 million versus the consensus estimate of $76.5 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• Jefferies Financial Group (JEF) Misses Q2 EPS by 22c
• Starwood Property Trust (STWD) Reiterated at Market Outperform by Citizens